Home  |  Sitemap  |  Email Page  |  Print Page  |  Contact   
VALIDUS
Validus is focused on acquiring, reformulating and marketing prescription products relevant to the psychiatry and neurology markets. Our business is based on acquisition of established products that have well defined and accepted clinical utility relevant to today's practice of medicine.
Press Releases
09.2007
11
Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro®  |  Read More
05.2007
14
Validus Pharmaceuticals Announces Acquisition of Marplan® (isocarboxazid) - A Highly Effective Therapy For Treatment-Resistant Depression  |  Read More